Cargando…

Correlation and Significance of Urinary Soluble Fas and Vascular Endothelial Growth Factor in Bladder Urothelial Cancer

Aim. To investigate the correlation and significance between the urine soluble Fas (sFas) and vascular endothelial growth factor (VEGF) expression in patients with urothelial bladder carcinoma (UC). Methods. The level of sFas was measured by enzyme-linked immunosorbent assay (ELISA) and the expressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Huixiang, Wang, Zhiyong, Guo, Yong, Wang, Zemin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698549/ https://www.ncbi.nlm.nih.gov/pubmed/26798188 http://dx.doi.org/10.1155/2015/383509

Ejemplares similares

Significance of Vascular Endothelial Growth Factor Expression in the Bladder Urothelial Carcinoma and Its Association with Tumor Grade and Invasiveness
por: Sadaf, Anika, et al.
Publicado: (2021)

Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladder
por: McNeil, Brian K, et al.
Publicado: (2014)

Prognostic significance of epidermal growth factor receptor (EGFR) over expression in urothelial carcinoma of urinary bladder
por: hashmi, Atif Ali, et al.
Publicado: (2018)

Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM
por: Bryan, R T, et al.
Publicado: (2015)

Urothelial Bladder Cancer Urinary Biomarkers
por: Noon, Aidan P, et al.
Publicado: (2014)

Soluble Fas and the −670 Polymorphism of Fas in Lupus Nephritis
por: Bollain-y-Goytia, Juan José, et al.
Publicado: (2014)

Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer
por: Hayashi, Yujiro, et al.
Publicado: (2020)

Diagnostic algorithm for papillary urothelial tumors in the urinary bladder
por: Shim, Jung-Weon, et al.
Publicado: (2008)

Nested variant of urothelial carcinoma of the urinary bladder
por: Terada, Tadashi
Publicado: (2011)

Clinical Significance of Substaging and HER2 Expression in Papillary Nonmuscle Invasive Urothelial Cancers of the Urinary Bladder
por: Lim, So Dug, et al.
Publicado: (2015)

Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer
por: Yang, Hanseul, et al.
Publicado: (2011)

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2020)

Review: Application of Nanoparticles in Urothelial Cancer of the Urinary Bladder
por: Chen, Chieh-Hsiao, et al.
Publicado: (2015)

Expression of Spred2 in the urothelial tumorigenesis of the urinary bladder
por: Oda, Shinsuke, et al.
Publicado: (2021)

Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract
por: Lee, Ji Yun, et al.
Publicado: (2017)

Clinicopathological Significance of Estrogen Receptor β and Estrogen Synthesizing/Metabolizing Enzymes in Urothelial Carcinoma of Urinary Bladder
por: Sato, Naomi, et al.
Publicado: (2021)

Serum Vascular Endothelial Growth Factor Levels Correlate with Severity of Retinopathy in Diabetic Patients: A Systematic Review and Meta-Analysis
por: Zhou, Zhongwei, et al.
Publicado: (2019)

Androgen Receptor: Evaluation and Correlation with Recurrence and Clinicopathological Parameters in Papillary Urothelial Carcinomas of the Urinary Bladder
por: Mumtaz, Shazia, et al.
Publicado: (2020)

Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder
por: Minato, Akinori, et al.
Publicado: (2018)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

Urothelial Papilloma of the Urinary Bladder in Children: Report of Two Cases
por: Davidovics, Kata, et al.
Publicado: (2020)

Alterations of Chromatin Regulators in the Pathogenesis of Urinary Bladder Urothelial Carcinoma
por: Hoffmann, Michèle J., et al.
Publicado: (2021)

Clinicopathological and prognostic significance of Ephrin A3 in bladder urothelial carcinoma
por: Wang, Yi-Fan, et al.
Publicado: (2023)

Matrix metalloproteinase-1, soluble Fas ligand, and soluble Fas antigen levels in patients with multiple organ dysfunction syndrome
por: Endo, S, et al.
Publicado: (1998)

Early septic insult in neonatal pigs increases serum and urinary soluble Fas ligand and decreases kidney function without inducing significant renal apoptosis
por: Soni, Hitesh, et al.
Publicado: (2016)

Elevated Concentrations of Soluble Fas and FasL in Multiple Sclerosis Patients with Antinuclear Antibodies
por: Sremec, Josip, et al.
Publicado: (2020)

Enhancing Production and Cytotoxic Activity of Polymeric Soluble FasL-Based Chimeric Proteins by Concomitant Expression of Soluble FasL
por: Morello, Aurore, et al.
Publicado: (2013)

Down-regulated claudin-7 immunoexpression in urothelial carcinoma of the urinary bladder
por: Gadelmoula, Mohamed, et al.
Publicado: (2013)

Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA
por: Togneri, Fiona S, et al.
Publicado: (2016)

Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014
por: Andreassen, B. K., et al.
Publicado: (2016)

Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract
por: Lonergan, Peter E., et al.
Publicado: (2020)

Pioglitazone Induces Dysplastic Urothelial Changes in Urinary Bladder of Experimental Diabetes
por: Abdel-Hamid, Ahmed A. M., et al.
Publicado: (2021)

Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
por: Chang, I-Wei, et al.
Publicado: (2016)

Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression
por: Yamana, K, et al.
Publicado: (2005)

Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients
por: Kimura, M, et al.
Publicado: (1999)

Comparison of the clonality of urothelial carcinoma developing in the upper urinary tract and those developing in the bladder
por: Wang, Yuding, et al.
Publicado: (2013)

Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis
por: Kim, Wan-Uk, et al.
Publicado: (2007)

Circulating soluble Fas levels and risk of ovarian cancer
por: Akhmedkhanov, Arslan, et al.
Publicado: (2003)

Soluble Fas Ligand Is Essential for Blister Formation in Pemphigus
por: Lotti, Roberta, et al.
Publicado: (2018)

Stronger Correlation between Interleukin 18 and Soluble Fas in Lupus Nephritis Compared with Mild Lupus
por: Hatef, Mohammad Reza, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cr4l0ge2r4qvdn6tko09lmslbk